(-)-demecolcine increases expression ISO RGD:736475 6480464 Demecolcine results in increased expression of TAP1 mRNA CTD PMID:23649840 1,2-dimethylhydrazine increases expression ISO RGD:11387 6480464 1, 2-Dimethylhydrazine results in increased expression of TAP1 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:736475 6480464 Estradiol results in increased expression of TAP1 mRNA CTD PMID:21185374 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of TAP1 mRNA CTD PMID:35192832 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TAP1 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO RGD:736475 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of TAP1 mRNA CTD PMID:30165855 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TAP1 mRNA CTD PMID:32741896 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:11387 6480464 2 more ... CTD PMID:30294300 2,2,2-trichloroethanol multiple interactions ISO RGD:736475 6480464 [HLA-B protein alternative form co-treated with 2 more ... CTD PMID:36423715 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11387 6480464 Tetrachlorodibenzodioxin affects the expression of TAP1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TAP1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TAP1 mRNA CTD PMID:34747641 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:736475 6480464 2 more ... CTD PMID:26705709 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of TAP1 mRNA CTD PMID:21346803 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one increases expression EXP 6480464 Praziquantel results in increased expression of TAP1 mRNA CTD PMID:21813463 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of TAP1 mRNA CTD PMID:14600272 2-tert-butylhydroquinone increases expression ISO RGD:736475 6480464 2-tert-butylhydroquinone results in increased expression of TAP1 mRNA CTD PMID:35724838 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3-methylcholanthrene increases expression ISO RGD:11387 6480464 Methylcholanthrene results in increased expression of TAP1 mRNA CTD PMID:29554273 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TAP1 mRNA CTD PMID:36041667 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of TAP1 mRNA CTD PMID:21893156 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of TAP1 mRNA CTD PMID:14600272 4-hydroperoxycyclophosphamide affects response to substance ISO RGD:736475 6480464 TAP1 protein affects the susceptibility to perfosfamide CTD PMID:18473730 4-hydroxyphenyl retinamide increases expression ISO RGD:11387 6480464 Fenretinide results in increased expression of TAP1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:736475 6480464 Decitabine affects the expression of TAP1 mRNA CTD PMID:23300844 5-fluorouracil multiple interactions ISO RGD:736475 6480464 TP53 protein promotes the reaction [Fluorouracil results in increased expression of TAP1 mRNA] CTD PMID:17982676 5-fluorouracil increases expression ISO RGD:736475 6480464 Fluorouracil results in increased expression of TAP1 mRNA CTD PMID:17982676 , PMID:20737486 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of TAP1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of TAP1 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:736475 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TAP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TAP1 mRNA CTD PMID:32699268 actinomycin D increases expression ISO RGD:736475 6480464 Dactinomycin results in increased expression of TAP1 mRNA CTD PMID:21527772 aflatoxin B1 affects expression ISO RGD:736475 6480464 Aflatoxin B1 affects the expression of TAP1 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:736475 6480464 Aflatoxin B1 results in increased expression of TAP1 mRNA CTD PMID:21632981 more ... aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TAP1 mRNA CTD PMID:14600272 more ... aflatoxin B1 increases expression ISO RGD:11387 6480464 Aflatoxin B1 results in increased expression of TAP1 mRNA CTD PMID:19770486 Aflatoxin G1 decreases expression ISO RGD:736475 6480464 aflatoxin G1 results in decreased expression of TAP1 mRNA, aflatoxin G1 results in decreased expression of TAP1 protein CTD PMID:20381597 all-trans-retinoic acid increases expression ISO RGD:736475 6480464 Tretinoin results in increased expression of TAP1 mRNA CTD PMID:15498508 more ... alpha-pinene multiple interactions ISO RGD:736475 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TAP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TAP1 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of TAP1 mRNA CTD PMID:16483693 andrographolide increases expression ISO RGD:736475 6480464 andrographolide results in increased expression of TAP1 mRNA CTD PMID:35724838 antirheumatic drug decreases expression ISO RGD:736475 6480464 Antirheumatic Agents results in decreased expression of TAP1 mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO RGD:736475 6480464 aristolochic acid I results in increased expression of TAP1 mRNA CTD PMID:33212167 arsane increases expression ISO RGD:736475 6480464 Arsenic results in increased expression of TAP1 mRNA CTD PMID:33736254 arsane multiple interactions ISO RGD:736475 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of TAP1 mRNA CTD PMID:33736254 arsenic atom multiple interactions ISO RGD:736475 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of TAP1 mRNA CTD PMID:33736254 arsenic atom increases expression ISO RGD:736475 6480464 Arsenic results in increased expression of TAP1 mRNA CTD PMID:33736254 arsenite(3-) multiple interactions ISO RGD:11387 6480464 TRP53 protein affects the reaction [arsenite results in decreased expression of TAP1 mRNA] CTD PMID:18929588 arsenite(3-) decreases expression ISO RGD:11387 6480464 arsenite results in decreased expression of TAP1 mRNA CTD PMID:18929588 arsenous acid decreases expression ISO RGD:736475 6480464 Arsenic Trioxide results in decreased expression of TAP1 mRNA CTD PMID:19128835 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of TAP1 gene CTD PMID:28931070 Bardoxolone methyl increases expression ISO RGD:736475 6480464 bardoxolone methyl results in increased expression of TAP1 mRNA CTD PMID:35724838 benzo[a]pyrene increases expression ISO RGD:11387 6480464 Benzo(a)pyrene results in increased expression of TAP1 mRNA CTD PMID:19770486 , PMID:23735875 benzo[a]pyrene multiple interactions ISO RGD:11387 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TAP1 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO RGD:736475 6480464 Benzo(a)pyrene results in increased expression of TAP1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:736475 6480464 7 more ... CTD PMID:19150397 benzo[a]pyrene diol epoxide I increases expression ISO RGD:736475 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene multiple interactions ISO RGD:11387 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TAP1 mRNA CTD PMID:27858113 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of TAP1 mRNA CTD PMID:21318169 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736475 6480464 Diethylhexyl Phthalate results in increased expression of TAP1 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate affects expression ISO RGD:11387 6480464 Diethylhexyl Phthalate affects the expression of TAP1 mRNA CTD PMID:27405655 bis(2-ethylhexyl) phthalate increases expression ISO RGD:11387 6480464 Diethylhexyl Phthalate results in increased expression of TAP1 mRNA CTD PMID:28085963 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TAP1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TAP1 mRNA CTD PMID:36041667 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TAP1 mRNA CTD PMID:34947998 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of TAP1 gene CTD PMID:28505145 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TAP1 mRNA CTD PMID:36041667 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of TAP1 mRNA CTD PMID:25993096 camptothecin increases expression ISO RGD:736475 6480464 Camptothecin results in increased expression of TAP1 mRNA CTD PMID:17374387 carbon nanotube decreases expression ISO RGD:11387 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:11387 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:736475 6480464 CGP 52608 promotes the reaction [RORA protein binds to TAP1 gene] CTD PMID:28238834 chloroform increases expression EXP 6480464 Chloroform results in increased expression of TAP1 mRNA CTD PMID:21813463 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of TAP1 mRNA CTD PMID:23125180 chromium(6+) affects expression ISO RGD:11387 6480464 chromium hexavalent ion affects the expression of TAP1 mRNA CTD PMID:28472532 chrysene multiple interactions ISO RGD:11387 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TAP1 mRNA CTD PMID:27858113 cisplatin increases expression ISO RGD:11387 6480464 Cisplatin results in increased expression of TAP1 mRNA CTD PMID:24280081 cisplatin multiple interactions ISO RGD:736475 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of TAP1 mRNA CTD PMID:27392435 cisplatin affects expression ISO RGD:736475 6480464 Cisplatin affects the expression of TAP1 mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:736475 6480464 Cisplatin results in increased expression of TAP1 mRNA CTD PMID:19561079 more ... Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of TAP1 mRNA CTD PMID:26577399 cyclophosphamide increases expression ISO RGD:736475 6480464 Cyclophosphamide results in increased expression of TAP1 mRNA CTD PMID:21527772 cyclosporin A increases expression ISO RGD:736475 6480464 Cyclosporine results in increased expression of TAP1 mRNA CTD PMID:20106945 , PMID:22147139 daunorubicin increases expression ISO RGD:736475 6480464 Daunorubicin results in increased expression of TAP1 mRNA CTD PMID:17374387 deoxynivalenol decreases expression ISO RGD:736475 6480464 deoxynivalenol results in decreased expression of TAP1 mRNA, deoxynivalenol results in decreased expression of TAP1 protein CTD PMID:15766417 dextran sulfate increases expression ISO RGD:11387 6480464 Dextran Sulfate results in increased expression of TAP1 mRNA CTD PMID:23894361 dextran sulfate multiple interactions ISO RGD:11387 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAP1 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:736475 6480464 Arsenic Trioxide results in decreased expression of TAP1 mRNA CTD PMID:19128835 dibenz[a,h]anthracene increases expression ISO RGD:11387 6480464 1 more ... CTD PMID:26377693 dichlorvos increases expression EXP 6480464 Dichlorvos results in increased expression of TAP1 mRNA CTD PMID:21813463 dieldrin decreases expression ISO RGD:736475 6480464 Dieldrin results in decreased expression of TAP1 mRNA CTD PMID:31068361 dimethylarsinous acid increases expression ISO RGD:736475 6480464 dimethylarsinous acid results in increased expression of TAP1 mRNA CTD PMID:20886546 dioxygen increases expression ISO RGD:11387 6480464 Oxygen deficiency results in increased expression of TAP1 mRNA CTD PMID:24205000 dorsomorphin multiple interactions ISO RGD:736475 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAP1 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:11387 6480464 Doxorubicin results in increased expression of TAP1 mRNA CTD PMID:22712078 elemental selenium increases expression ISO RGD:736475 6480464 Selenium results in increased expression of TAP1 mRNA CTD PMID:19244175 entinostat increases expression ISO RGD:736475 6480464 entinostat results in increased expression of TAP1 mRNA CTD PMID:27188386 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of TAP1 mRNA CTD PMID:15353170 ethyl methanesulfonate increases expression ISO RGD:736475 6480464 Ethyl Methanesulfonate results in increased expression of TAP1 mRNA CTD PMID:23649840 etoposide increases expression ISO RGD:736475 6480464 Etoposide results in increased expression of TAP1 mRNA CTD PMID:17374387 , PMID:21527772 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of TAP1 mRNA CTD PMID:18035473 formaldehyde increases expression ISO RGD:736475 6480464 Formaldehyde results in increased expression of TAP1 mRNA CTD PMID:23649840 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of TAP1 mRNA CTD PMID:22061828 , PMID:33387578 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of TAP1 mRNA CTD PMID:24395379 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of TAP1 mRNA CTD PMID:16452686 hexadecanoic acid multiple interactions ISO RGD:736475 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of TAP1 mRNA CTD PMID:33736254 hydrogen peroxide affects expression ISO RGD:736475 6480464 Hydrogen Peroxide affects the expression of TAP1 mRNA CTD PMID:20044591 hydroxyurea increases expression ISO RGD:11387 6480464 Hydroxyurea results in increased expression of TAP1 mRNA CTD PMID:27208086 ivermectin decreases expression ISO RGD:736475 6480464 Ivermectin results in decreased expression of TAP1 protein CTD PMID:32959892 lipopolysaccharide increases expression ISO RGD:736475 6480464 Lipopolysaccharides results in increased expression of TAP1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:736475 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TAP1 mRNA CTD PMID:35811015 mercury atom decreases expression EXP 6480464 Mercury results in decreased expression of TAP1 mRNA CTD PMID:22688007 mercury(0) decreases expression EXP 6480464 Mercury results in decreased expression of TAP1 mRNA CTD PMID:22688007 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of TAP1 mRNA CTD PMID:21813463 methidathion increases expression ISO RGD:11387 6480464 methidathion results in increased expression of TAP1 mRNA CTD PMID:34813904 methyl methanesulfonate increases expression ISO RGD:736475 6480464 Methyl Methanesulfonate results in increased expression of TAP1 mRNA CTD PMID:21527772 , PMID:23649840 mitoxantrone affects response to substance ISO RGD:736475 6480464 TAP1 protein affects the susceptibility to Mitoxantrone CTD PMID:17523305 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of TAP1 mRNA CTD PMID:21813463 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of TAP1 mRNA CTD PMID:14600272 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of TAP1 mRNA CTD PMID:19716841 N-Nitrosopyrrolidine increases expression ISO RGD:736475 6480464 N-Nitrosopyrrolidine results in increased expression of TAP1 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:736475 6480464 Nickel results in increased expression of TAP1 mRNA CTD PMID:25583101 nickel atom multiple interactions EXP 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of TAP1 mRNA CTD PMID:31734292 nickel sulfate increases expression ISO RGD:736475 6480464 nickel sulfate results in increased expression of TAP1 mRNA CTD PMID:22714537 nickel sulfate multiple interactions EXP 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of TAP1 mRNA CTD PMID:31734292 nimustine affects response to substance ISO RGD:736475 6480464 TAP1 protein affects the susceptibility to Nimustine CTD PMID:17523305 ozone multiple interactions ISO RGD:736475 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TAP1 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:11387 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TAP1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TAP1 mRNA CTD PMID:34911549 paclitaxel increases expression ISO RGD:736475 6480464 Paclitaxel results in increased expression of TAP1 mRNA CTD PMID:20737486 paracetamol increases expression ISO RGD:736475 6480464 Acetaminophen results in increased expression of TAP1 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of TAP1 mRNA CTD PMID:33387578 pentachlorophenol increases expression ISO RGD:11387 6480464 Pentachlorophenol results in increased expression of TAP1 mRNA CTD PMID:23892564 perfluorohexanesulfonic acid decreases expression ISO RGD:736475 6480464 perfluorohexanesulfonic acid results in decreased expression of TAP1 mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO RGD:736475 6480464 perfluoro-n-nonanoic acid results in decreased expression of TAP1 mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:11387 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of TAP1 mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:736475 6480464 perfluorooctane sulfonic acid results in decreased expression of TAP1 mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO RGD:736475 6480464 perfluorooctanoic acid results in decreased expression of TAP1 mRNA CTD PMID:25812627 pirinixic acid multiple interactions ISO RGD:11387 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of TAP1 mRNA CTD PMID:20813756 pirinixic acid decreases expression ISO RGD:11387 6480464 pirinixic acid results in decreased expression of TAP1 mRNA CTD PMID:20813756 pyrrolidine dithiocarbamate multiple interactions ISO RGD:736475 6480464 [pyrrolidine dithiocarbamic acid co-treated with HLA-B protein alternative form] results in decreased expression of TAP1 protein more ... CTD PMID:36423715 quercetin increases expression ISO RGD:736475 6480464 Quercetin results in increased expression of TAP1 mRNA CTD PMID:21632981 resveratrol increases expression ISO RGD:11387 6480464 resveratrol results in increased expression of TAP1 protein CTD PMID:25505154 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:736475 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TAP1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:736475 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAP1 mRNA CTD PMID:27188386 selenium atom increases expression ISO RGD:736475 6480464 Selenium results in increased expression of TAP1 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:736475 6480464 Silicon Dioxide results in increased expression of TAP1 mRNA CTD PMID:25351596 silver atom increases expression ISO RGD:736475 6480464 Silver results in increased expression of TAP1 mRNA CTD PMID:28959546 silver atom decreases expression ISO RGD:11387 6480464 Silver results in decreased expression of TAP1 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:736475 6480464 Silver results in increased expression of TAP1 mRNA CTD PMID:28959546 silver(0) decreases expression ISO RGD:11387 6480464 Silver results in decreased expression of TAP1 mRNA CTD PMID:27131904 sodium dichromate decreases expression ISO RGD:11387 6480464 sodium bichromate results in decreased expression of TAP1 mRNA CTD PMID:22155349 Soman increases expression EXP 6480464 Soman results in increased expression of TAP1 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:11387 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TAP1 mRNA CTD PMID:21641980 sulforaphane increases expression ISO RGD:736475 6480464 sulforaphane results in increased expression of TAP1 mRNA CTD PMID:35724838 tamibarotene increases expression ISO RGD:736475 6480464 tamibarotene results in increased expression of TAP1 mRNA CTD PMID:15498508 tamoxifen decreases expression ISO RGD:11387 6480464 Tamoxifen results in decreased expression of TAP1 mRNA CTD PMID:25123088 tamoxifen affects expression ISO RGD:11387 6480464 Tamoxifen affects the expression of TAP1 mRNA CTD PMID:20937368 temozolomide increases expression ISO RGD:736475 6480464 Temozolomide results in increased expression of TAP1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide increases expression ISO RGD:11387 6480464 tert-Butylhydroperoxide results in increased expression of TAP1 mRNA CTD PMID:14729362 , PMID:15003993 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TAP1 mRNA CTD PMID:32741896 tetrachloromethane affects expression ISO RGD:11387 6480464 Carbon Tetrachloride affects the expression of TAP1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:11387 6480464 PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of TAP1 mRNA] CTD PMID:18038451 tetraphene multiple interactions ISO RGD:11387 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TAP1 mRNA CTD PMID:27858113 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TAP1 mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:11387 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TAP1 mRNA CTD PMID:29950665 Tributyltin oxide increases expression ISO RGD:11387 6480464 bis(tri-n-butyltin)oxide results in increased expression of TAP1 mRNA CTD PMID:18958704 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of TAP1 mRNA CTD PMID:33387578 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of TAP1 mRNA CTD PMID:21893156 Triptolide increases expression EXP 6480464 triptolide results in increased expression of TAP1 protein CTD PMID:32519852 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of TAP1 mRNA CTD PMID:21318169 valproic acid increases expression ISO RGD:736475 6480464 Valproic Acid results in increased expression of TAP1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:736475 6480464 Valproic Acid affects the expression of TAP1 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of TAP1 mRNA CTD PMID:22570695 vincristine increases expression ISO RGD:736475 6480464 Vincristine results in increased expression of TAP1 mRNA CTD PMID:23649840 vorinostat multiple interactions ISO RGD:736475 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAP1 mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:736475 6480464 vorinostat results in increased expression of TAP1 mRNA CTD PMID:27188386 zinc atom increases expression ISO RGD:736475 6480464 Zinc deficiency results in increased expression of TAP1 mRNA CTD PMID:22171008 zinc(0) increases expression ISO RGD:736475 6480464 Zinc deficiency results in increased expression of TAP1 mRNA CTD PMID:22171008